metricas
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Value of 18F-FDG PET/CT in the diagnosis and grading of incidental colorectal ad...
Journal Information
Vol. 44. Issue 2.
(March - April 2025)
Cite
Cite
Share
Download PDF
More article options
Visits
1997
Vol. 44. Issue 2.
(March - April 2025)
Original Article

Value of 18F-FDG PET/CT in the diagnosis and grading of incidental colorectal adenomas

Valor de 18F-FDG PET/CT en el diagnóstico y la gradación de Adenomas colorrectales incidentales
Visits
1997
Z. Qia, K. Tangb, X. Luc, Y. Zhuc, N. Xuc,
Corresponding author
15258868408@163.com

Corresponding author.
a Department of Gastroenterology, Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
b Department of Nuclear Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
c Department of Medical Imaging (Radiology), the Affiliated Hospital of Hangzhou Normal University, Hangzhou, China
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Abstract
Purpose

Colorectal adenomas (CRAs) are at a higher risk of progressing to colorectal cancer (CRC) as their histological grade increases. Herein, this study investigated the relationship between the maximum standardized uptake value (SUVmax) on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) and the histological grades of CRAs and constructed the optimal regression model for distinguishing between different histological grades.

Methods

This study retrospectively analyzed the data of 153 patients with CRAs who had colorectal 18F-FDG uptake incidentally found on PET/CT. The patients were categorized into low-grade intraepithelial neoplasia (LGIN) and high-grade intraepithelial neoplasia (HGIN) groups based on their histological grade. After the analysis of the relationship between SUVmax measured on preoperative 18F-FDG PET/CT scans and histological grades, receiver-operating characteristic (ROC) curves were analyzed to determine the optimal cut-off values for distinguishing between the two groups. Common clinical and pathological factors were included and subjected to univariate and multivariate logistic regression analyses to identify independent risk factors. A diagnostic model integrating SUVmax and several risk factors was developed with the multivariate logistic regression analysis.

Results

SUVmax was significantly different between the two groups (P < 0.001) and increased with an elevation in the malignancy degree. The area under the ROC curve (AUC) for identifying LGIN and HGIN was 0.796, and the AUC of the combination model was 0.822. Furthermore, SUVmax was an independent risk factor for distinguishing between different histological grades in pairwise comparisons.

Conclusion

The regression model involving SUVmax on 18F-FDG PET/CT can distinguish between histological grades of CRAs, which therefore can be used as a noninvasive tool for the accurate diagnosis of CRAs and assist in developing patient-specific treatment strategies before surgery.

Keywords:
PET/CT
18F-fluorodeoxyglucose
Incidental colorectal adenomas
Colonoscopy
Histopathology
Resumen
Propósito

Los adenomas colorrectales (CRAs) tienen un riesgo más alto de evolucionar a cáncer colorrectal (CRC) a medida que aumenta su grado histológico. En el presente estudio se investigó la relación entre el valor máximo de captación estandar (SUVmax) en la tomografia por emisión de positrones junto con tomografia computerizada con 18F-fluorodesoxiglu- (18F-FDG PET/TC) y los grados histológicos de los CRAs y se construyó el modelo de regresión óptimo para distinguir entre los diferentes grados histológicos.

Métodos

En este estudio se analizaron retrospeclos datos de 153 pacientes con CRAs que tenían captación colorrectal de 18F-FDG encontrada incidentemente en PET/CT. Los pacientes se clasificaron en los grupos de neoplasia intraepitelial grado bajo (LGIN) y de neoplasia intraepitelial grado alto (HGIN) según su grado histológico. Después del análisis de la relación entre el SUVmax medido en las exploraciones PET/CT preoperatorio con 18F-FDG y los grados histológicos, se analizaron las curvas características de funcionamiento del receptor (ROC) para determinar los valores de corte óptimos para distinguir entre los dos grupos. Se incluyeron factores clínicos y patológicos comunes y se realizaron análisis de regresión logística univariable y multivaripara identificar factores de riesgo independientes. Con el análisis de regresión logística multivarise desarrolló un modelo diagnóstico que integra SUVmax y varios factores de riesgo.

Resultados

El SUVmax fue significativamente diferente entre los dos grupos (P < 0,001) y aumentó con la elevación del grado de malignidad. El área bajo la curva ROC (AUC) para la identificación de LGIN y HGIN fue de 0,796, y el AUC del modelo de combinación fue de 0,822. Además, SUVmax fue un factor de riesgo independiente para distinguir entre diferentes grados histológicos en comparaciones por pares.

Conclusión

El modelo de regresión que involucra SUVmax en 18F-FDG PET/TC puede distinguir entre los grados histológicos de los CRAs, que por lo tanto pueden ser utilizados como una herramienta no invasiva para el diagnóstico preciso de los CRAs y ayudar en el desarrollo de estrategias de tratamiento específicas para el paciente antes de la cirugía.

Palabras clave:
PET/CT
18f-fluorodesoxiglucosa
Adenomas colorrectales incidentales
Colonoscopia
Histhist

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
K.A. Delman.
Introducing the "Virtual Tumor Board" series in CA: A Cancer Journal for Clinicians.
CA Cancer J Clin, 70 (2020), pp. 77
[2]
W.B. Gaertner, et al.
Rectal cancer: an evidence-based update for primary care providers.
World J Gastroenterol, 21 (2015), pp. 7659-7671
[3]
V.W. Wong, et al.
High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.
[4]
M.K. Washington, et al.
Diagnosis of digestive system tumours.
Int J Cancer, 148 (2021), pp. 1040-1050
[5]
S. Winawer, et al.
Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence.
Gastroenterology, 124 (2003), pp. 544-560
[6]
S. Tsutsumi, et al.
[A case of double cancer of squamous cell carcinoma of the rectum and adenocarcinoma of the sigmoid colon].
Gan To Kagaku Ryoho, 50 (2023), pp. 1423-1425
[7]
D.K. Rex, et al.
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology.
Am J Gastroenterol, 95 (2000), pp. 868-877
[8]
D.A. Mankoff, J.R. Bellon.
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
Semin Radiat Oncol, 11 (2001), pp. 16-27
[9]
N.C. Purandare, et al.
Etiology and significance of incidentally detected focal colonic uptake on FDG PET/CT.
Indian J Radiol Imaging, 22 (2012), pp. 260-266
[10]
R. Minamimoto, et al.
Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
Ann Nucl Med, 28 (2014), pp. 212-219
[11]
T. Liu, et al.
Focal colonic FDG activity with PET/CT: guidelines for recommendation of colonoscopy.
World J Nucl Med, 14 (2015), pp. 25-30
[12]
S. Yasuda, A. Shohtsu, Y. Tsutsumi.
Colonic adenoma detected by positron emission tomography (PET): a case report.
Tokai J Exp Clin Med, 23 (1998), pp. 153-155
[13]
T. Ivic-Pavlicic, et al.
The association between food insecurity and colorectal cancer screening: 2018-2021 New York State Behavioral Risk Factor Surveillance System (BRFSS).
Cancer Causes Control, 35 (2024), pp. 1565-1572
[14]
G.B. Baretton, A. Tannapfel, W. Schmitt.
[Standardized and structured histopathological evaluation of colorectal polyps: a practical checklist against the background of the new WHO classification].
Pathologe, 32 (2011), pp. 289-296
[15]
A. Arezzo, et al.
Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Societa Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.
Tech Coloproctol, 19 (2015), pp. 587-593
[16]
W. Luboldt, et al.
Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off.
Eur Radiol, 20 (2010), pp. 2274-2285
[17]
F. Miraldi, et al.
Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer.
[18]
S.Y. Na, et al.
Who should undergo a colonoscopy among patients with incidental colon uptake on PET-CT?.
Scand J Gastroenterol, 50 (2015), pp. 1045-1053
[19]
M. Sekiguchi, et al.
Sensitivity of 2-[(18)F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals.
J Gastroenterol, 51 (2016), pp. 1122-1132
[20]
G. Treglia, et al.
Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis.
Radiol Oncol, 48 (2014), pp. 99-104
[21]
C.H. Park, et al.
Optimization of the surveillance strategy in patients with colorectal adenomas: a combination of clinical parameters and index colonoscopy findings.
J Gastroenterol Hepatol, 36 (2021), pp. 974-982
[22]
H.Y. Shin, et al.
The effect of changing stool collection processes on compliance in nationwide organized screening using a fecal occult blood test (FOBT) in Korea: study protocol for a randomized controlled trial.
[23]
U. Haug, et al.
Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.
Int J Cancer, 136 (2015), pp. 2864-2874
[24]
J. Pitkaniemi, et al.
Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland.
BMJ Open Gastroenterol, 2 (2015), pp. e000034
[25]
Z. Pengjun, et al.
Multiplexed cytokine profiling of serum for detection of colorectal cancer.
Future Oncol, 9 (2013), pp. 1017-1027
[26]
B. Levin, et al.
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.
CA Cancer J Clin, 58 (2008), pp. 130-160
[27]
C. Garrido Duran, et al.
Clinical-endoscopic relevance of incidental colorectal lesions detected by PET-CT.
Rev Esp Enferm Dig, 110 (2018), pp. 434-439
[28]
S.W. Huang, et al.
A comparison of positron emission tomography and colonoscopy for the detection of advanced colorectal neoplasms in subjects undergoing a health check-up.
[29]
D.G. Menter, et al.
Back to the colorectal cancer consensus molecular subtype future.
Curr Gastroenterol Rep, 21 (2019), pp. 5
[30]
M.A. Komor, et al.
Consensus molecular subtype classification of colorectal adenomas.
J Pathol, 246 (2018), pp. 266-276
asdasdasd
Article options
Tools